February 1, 2019 / 11:10 AM / 21 days ago

Novo Nordisk CEO backs ending drug industry rebate system

COPENHAGEN, Feb 1 (Reuters) - The chief executive of drugmaker Novo Nordisk on Friday welcomed a proposal calling for an end to the industry practice of offering after-market discounts called rebates to pharmacy benefit managers.

“We applaud the proposal. It’s not perfectly clear yet exactly how it could be implemented,” CEO Lars Fruergaard Jorgensen told journalists following the release of the company’s fourth-quarter results.

Reporting by Stine Jacobsen; editing by Jason Neely

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below